Dissecting signaling regulators driving AXL-mediated bypass resistance and associated phenotypes by phosphosite perturbations
M. Creixell, S. D. Taylor, J. Gerritsen, S. Y. Bae, M. Jiang, T. Augustin, M. Loui, C. Boixo, P. Creixell, F. M. White, A. S. Meyer
The paper uses phosphosite perturbations to identify signaling pathways driving AXL-mediated erlotinib resistance in lung cancer.
bioRxiv · Oct 20, 2023 · PreprintCancer Biology